Ignite Creation Date:
2024-07-17 @ 10:53 AM
Last Modification Date:
2024-10-26 @ 3:32 PM
Study NCT ID:
NCT06461650
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-06-17
First Post:
2024-06-11
Brief Title:
Preoperative Nicotine Cessation for Women With Breast Cancer Recommended for Reconstruction
Sponsor:
University of Florida
Organization:
University of Florida
Study Overview
Official Title:
Preoperative Nicotine Cessation for Women With Breast Cancer Recommended for Reconstruction
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Close to 20 of cancer patients currently use nicotine products Nicotine use in breast cancer patients is associated with poorer overall outcomes including worsened survival and increased surgical complications Nicotine cessation is rarely addressed in breast cancer patients at the time of diagnosis and may be a missed opportunity to optimize patient outcomes Patients that use nicotine products are not offered reconstruction at time of mastectomy or oncoplastics at the time of lumpectomy which can be emotionally distressing in women with breast cancer Reconstruction could be an additional motivating factor in nicotine cessation success
This study aims to evaluate the feasibility of a nicotine cessation program designed by Area Health Education Center AHEC in the target population The study is designed to test the acceptability and preliminary efficacy of a formal nicotine cessation program in women actively using nicotine products with breast cancer recommended for reconstructive or oncoplastics surgery
This study aims to evaluate the feasibility of a nicotine cessation program designed by Area Health Education Center AHEC in the target population The study is designed to test the acceptability and preliminary efficacy of a formal nicotine cessation program in women actively using nicotine products with breast cancer recommended for reconstructive or oncoplastics surgery
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None